Expression of heregulin in human coronary atherosclerotic lesions

Journal of Vascular Research

Volumn 42, Issue 6, 2005, Pages 463-474

  Panutsopulos, Dimitrios ^a   Arvanitis, Dimitrios L ^b   Tsatsanis, Christos ^a   Papalambros, Efstathios ^c   Sigala, Fragiska ^c   Spandidos, Demetrios A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Angiogenesis; Coronary disease; Growth factors; Macrophages

Indexed keywords

NEU DIFFERENTIATION FACTOR;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; AUTOPSY; CELL ACTIVATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; EVALUATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; NEUREGULIN-1; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27344455451     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088100     Document Type: Article

References (36)

1. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med 1999;340:115-126.
2. Lusis AJ: Atherosclerosis. Nature 2000;407:233-241.
3. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
4. Alroy I, Yarden Y: The ErbB signalling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett 1997;410:83-86.
5. Riese DJ, Stern DF: Specificity within the EGF family/ErbB receptor family signalling network. Bioessays 1998;20:41-48.
6. Lupu R, Colomer R, Kannan B, et al: Characterization of growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses. Proc Natl Acad Sci USA 1992;89:2287-2291.
7. Bacus SS, Huberman E, Chin D, et al: A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells. Cell Growth Differ 1992;3:401-411.
8. Guerra-Vladusic FK, Scott G, Weaver V, et al: Constitutive expression of Heregulin induces apoptosis in an erbB-2 overexpressing breast cancer cell line SKBr-3. Int J Oncol 1999;15:883-892.
9. Tripathy D, Benz CC: Activated oncogenes and putative tumor suppressor genes involved in human breast cancers. Cancer Treat Res 1992;63:15-60.
10. Mograbi B, Rochet N, Imbert V, et al: Human monocytes express amphiregulin and heregulin growth factors upon activation. Eur Cytokine Netw 1997;8:73-81.
11. Moussad EE, Brigstock DR: Connective tissue growth factor: what's in a name? Mol Genet Metab 2000;71:276-292.
12. Yang PG, Lau FL: Cyr61, product of a growth factor-induced immediate early gene, is associated with the extracellular matrix and the cell surface. Cell Growth Differ 1991;2:351-357.
13. Lau LF, Lam SC: The CCN of angiogenic regulators: the integrin connection. Exp Cell Res 1999;248:44-57.
14. Perbal B: NOV (nephroblastoma overexpressed) and the CCN family of genes: structural and functional issues. Mol Pathol 2001;54:57-79.
15. Kireeva ML, Mo F, Yang GP, et al: Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol 1996;16:1326-1334.
16. 1 in human umbilical vein endothelial cells. J Biol Chem 2002;277:46248-46255.
17. 2 as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood 2002;99:4457-4465.
18. Springer TA: Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-314.
19. Hilfiker A, Hilfiker-Kleiner D, Fuchs M, et al: Expression of CYR61, an angiogenic immediate early gene, in atherosclerosis and its regulation by angiotensin II. Circulation 2002;106:254-260.
20. Edgell CJS, McDonald CC, Graham JB: Permanent cell line expressing factor VIII related antigen established by hybridization. Proc Natl Acad Sci USA 1983;80:3734-3737.
21. Rieber AJ, Marr HS, Comer MB, et al: Extent of differentiated gene expression in human endothelium-derived EA.hy926. Thromb Haemost 1993;69:476-480.
22. Stary HC, Chandler AB, Dinsmore RE, et al: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355-1374.
23. Hakkinen T, Karkola K, Yla-Herttuala S: Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows Arch 2000;437:396-405.
24. Panutsopulos D, Zafiropoulos A, Krambovitis E, et al: Peripheral monocytes from diabetic patients with coronary artery disease display increased bFGF and VEGF mKNA expression. J Transl Med 2003;1:6.
25. Tsai MS, Shamon-Taylor LA, Mehmi I, et al: Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer. Oncogene 2003;22:761-768.
26. Yen L, Benlimame N, Nie ZR, et al: Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers. Mol Biol Cell 2002;13:4029-4044.
27. Kireeva ML, Latinkic BV, KolesnikovaTV, et al: Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res 1997;233:63-77.
28. Latinkic BV, Mo F-E, Greenspan JA, et al: Promoter function of the angiogenic inducer Cyr61 gene in transgenic mice: tissue specificity, inducibility during wound healing, and role of the serum response element. Endocrinology 2001;142:2549-2557.
29. O'Brien TP, Yang GP, Sanders L, et al: Expression of cyr61, a growth factor-inducible immediate-early gene. Mol Cell Biol 1990;10:3569-3577.
30. Ryseck RP, Macdonald-Bravo H, Mattei MG, et al: Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ 1991;2:225-233.
31. Raines EW, Ross R: Multiple growth factors are associated with lesions of atherosclerosis: specificity or redundancy? Bioessays 1996;18:271-282.
32. Rutanen J, Leppanen P, Tuomisto TT, et al: Vascular endothelial growth factor-D expression in human atherosclerotic lesions. Cardiovasc Res 2003;59:971-979.
33. Inoue M, Itoh H, Ueda M, et al: Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. Circulation 1998;98:2108-2116.
34. Babic AM, Kireeva ML, Kolesnikova TV, et al: CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA 1998;95:6355-6360.
35. 3, promotes endothelial cell survival, and induces angiogenesis in vivo. Mol Cell Biol 1999;19:2958-2966.
36. Tsai MS, Hornby AE, Lakins J, et al: Expression and function of CYR61, an angiogenic factor, in breast cancer cell lines and tumor biopsies. Cancer Res 2000;60:5603-5607.